Why this drug could become 'better than a $10B product': Johnson & Johnson CFO

Yahoo Finance Video and Julie Hyman Tue, October 13, 2026 at 4:51 PM GMT+2 $JNJ+WL Johnson & Johnson ( $JNJ+WL ) reported quarterly earnings on Tuesday and raised its full-year outlook. Johnson & Johnson CFO Joseph Wolk sits down with Yahoo Finance's Julie Hyman to discuss the company's strong drug sales numbers, highlighting the excitement surrounding two medications in particular. Video Transcript 00:00 Speaker A You mentioned um Icotide, which has been one of your areas of strength uh to treat psoriasis. Um prescriptions I believe for that just about doubled. You're not um revealing revenue from that yet, but I'm curious of those prescriptions, how much of them are sort of early free samples to get people interested and, you know, to find out that the that it's working for them.